Cara Therapeutics, Inc. Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
5/3/2012 11:21:29 AM
More...
|
Scottish Biomedical – Korean Life Science Collaboration Continues
2/2/2006 5:31:40 PM
More...
|